Smartphone-based Self-management in COPD Patients: A Needs Assessment Survey

April 11, 2022 updated by: Dr. Agnes Yuen-Kwan Lai, The University of Hong Kong

A Smartphone-based Self-management Support Program for Patients With Chronic Obstructive Pulmonary Disease - A Needs Assessment Survey

COPD patients often experience multiple symptoms (e.g. dyspnea, cough, and deteriorating quality of life) and have imposed a substantial economic and social burden on health care.

The current proposal is to explore the information needs of COPD patients and to evaluate the feasibility and acceptability of a smartphone-based instant messaging self-management support program to improve the quality of life in patients with COPD.

Study Overview

Status

Recruiting

Detailed Description

Chronic obstructive pulmonary disease (COPD) is the number 3 killer globally by 2020. COPD patients often experience multiple symptoms (e.g. dyspnea, cough, and deteriorating quality of life) and have imposed a substantial economic and social burden on health care.

Current policy for the prevention and management of long-term conditions focuses on efforts to prevent the onset or slow progression of disease early in the disease trajectory. This prevention paradigm has only recently been adopted for COPD. Systematic reviews have shown self-management support for patients with COPD is effective in improving health-related quality of life and in reducing hospital admissions, but the evidence comes largely from patients with moderate or severe disease and is predominantly recruited from secondary care. Simple and systematic strategies are needed to improve out-of-hospital support and management for people living with COPD.

An instant messaging smartphone app, which allows texts, audio, pictures and video messages to be shared in chat groups, is already available to and is the most popular in the Hong Kong general public. Mobile instant messaging can be conducted through a daily use device to increase access and efficacy, which has been suggested as a feasible approach to delivering an intervention with positive effects on health behaviours and outcomes. Text messaging via mobile phones has been shown to be effective in helping promote lifestyle change in diabetes self-management, weight loss, physical activity, smoking cessation and medication adherence with quantitative and qualitative evidence. However, we have not found messaging intervention that was applied in people with COPD, except an ongoing study of using instant text message support for patients with chronic respiratory and cardiovascular diseases.

Hence, the current proposal is to use a quantitative survey and qualitative interview exploring the information needs of COPD patients and evaluating the feasibility and acceptability of a smartphone-based instant messaging self-management support program to improve the quality of life in patients with COPD.

Study Type

Observational

Enrollment (Anticipated)

50

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Contact

  • Name: Asa Choi, MA
  • Phone Number: 852-3917-6563
  • Email: asachoi@hku.hk

Study Contact Backup

  • Name: Agnes YK Lai, PhD
  • Phone Number: 852-3917-6328
  • Email: agneslai@hku.hk

Study Locations

      • Hong Kong, Hong Kong
        • Recruiting
        • Queen Mary Hospital
        • Contact:
          • Agnes Lai, PhD
          • Phone Number: 852-2917-6283
        • Contact:
          • David Lam, PhD
          • Phone Number: 852-2255-4455
          • Email: singa@hku.hk

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

18 years and older (Adult, Older Adult)

Accepts Healthy Volunteers

No

Genders Eligible for Study

All

Sampling Method

Non-Probability Sample

Study Population

Patients with COPD

Description

Inclusion criteria

  • Aged 18 years and above
  • Diagnosis with COPD
  • Able to speak and read Chinese
  • Able to complete the self-administered questionnaire
  • Mental, cognitive and physically fit determined by the clinician or responsible investigator
  • Signed informed consent

Exclusion criteria

  • Serious active infection
  • Severe respiratory insufficiency

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Information and support needs
Time Frame: Baseline
Information preferences and needs of support measured by outcome-based questions
Baseline

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Patient Activation
Time Frame: Baseline
Knowledge, skills and confidence in self-management measured by a 13-item Patient Activation Measure
Baseline
Technological literacy
Time Frame: Baseline
Knowledge and confidence in using instant messaging measured by outcome-based questions
Baseline
Attitude towards smartphone-based intervention
Time Frame: Baseline
Attitude towards smartphone-based intervention measured by outcome-based questions
Baseline

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Publications and helpful links

The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

December 1, 2021

Primary Completion (Anticipated)

December 31, 2022

Study Completion (Anticipated)

December 31, 2022

Study Registration Dates

First Submitted

November 27, 2021

First Submitted That Met QC Criteria

November 27, 2021

First Posted (Actual)

December 9, 2021

Study Record Updates

Last Update Posted (Actual)

April 13, 2022

Last Update Submitted That Met QC Criteria

April 11, 2022

Last Verified

April 1, 2022

More Information

Terms related to this study

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

YES

IPD Plan Description

Need to obtain consent from patients before agreeing to share individual participants data.

IPD Sharing Time Frame

When study finished

IPD Sharing Access Criteria

The minimal anonymized dataset will be available upon request to interested researchers. For interested researchers, please contact, Ms Asa Choi (email asachoi@hku.hk), (School of Nursing, The University of Hong Kong) for further information.

IPD Sharing Supporting Information Type

  • STUDY_PROTOCOL

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Chronic Obstructive Pulmonary Disease

Subscribe